|
|
|
| Changing systems: a new strategy for overweight and obesity prevention and control |
| YE Zhen
|
| Zhejiang Zhijiang Life and Health Institute, Hangzhou, Zhejiang 310000, China |
|
|
|
|
Abstract The prevalence of overweight and obesity has been on rising steadily, posing a major challenge to public health. Focusing on changing systems, a new strategy for overweight and obesity prevention and control, this article elaborates on five pillars: government-led efforts to cultivate a sense of shared responsibility among four stakeholders, scientific weight management advocating multi-disciplinary collaborative diagnosis and treatment, precision management covering the entire population throughout the life cycle, policy incentives to optimize obesity-prone environments, and digital and intelligent empowerment to reshape the paradigm of weight management. However, overweight and obesity prevention and control face persistent challenges, including the difficulty of sustaining individual behavior change, the lack of supportive social environments, and the obstacles to implementing precise interventions. It is recommended to begin by shifting societal perceptions, collaborate across multiple sectors to implement a multi-pronged strategy, and promote highly effective and cost-efficient interventions.
|
|
Received: 09 October 2025
Revised: 27 October 2025
Published: 20 November 2025
|
|
|
|
|
|
[1] NCD Risk Factor Collaboration(NCD-RIsC).Worldwide trends in underweight and obesity from 1990 to 2022:a pooled analysis of 3 663 population-representative studies with 222 million children,adolescents,and adults[J].Lancet,2024,403(10431):1027-1050.
[2] World Obesity Federation.World obesity atlas 2025[M].London:WOF,2025.
[3] GBD 2019 Risk Factors Collaborators.Global burden of 87 risk factors in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019BD 2019 Risk Factors Collaborators.Global burden of 87 risk factors in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1223-1249.
[4] KOSKINAS K C,VAN CRAENENBROECK E M,ANTONIADES C,et al.Obesity and cardiovascular disease:an ESC clinical consensus statement[J].Eur Heart J,2024,45(38):4063-4098.
[5] CHIA A,ONG J,BUNDELE A,et al.Social entrepreneurship in obesity prevention:a scoping review[J/OL].Obes Rev,2022,23[2025-10-27]. https://doi.org/10.1111/obr.13378.
[6] World Health Organization.WHO acceleration plan to stop obesity[EB/OL].[2025-10-27].https://www.who.int/publications/i/item/9789240075634.
[7] 新华社. 国家卫生健康委主任:持续推进“体重管理年”行动[EB/OL].[2025-10-27].https://www.news.cn/20250309/5bb7bbd6208d4a3282f3022564bcc4bb/c.html.
[8] 国家体育总局.体育总局关于印发《关于推动运动促进健康事业高质量发展的指导意见》的通知[EB/OL].[2025-09-27].https://www.sport.gov.cn/n315/n20001395/c29071988/content.html.
[9] DANG J J,LIU Y F,CAI S,et al.Secular trend and projection of overweight and obesity among Chinese children and adolescents aged 7-18 years from 1985 to 2019:rural areas are becoming the focus of investment[J].Chin Med J,2025,138(3):311-317.
[10] 国家卫生健康委办公厅.肥胖症诊疗指南(2024年版)[EB/OL].[2025-10-27].https://www.nhc.gov.cn/wjw/c100378/202410/bcf804e19e0c4246b5aea6cd338b55e1/files/1732873189749_61795.pdf.
[11] 内分泌代谢科肥胖诊疗联盟,中国医师协会内分泌代谢科医师分会肥胖学组.体重管理门诊建设专家指导意见(2025版)[J].中华糖尿病杂志,2025,17(7):801-805.
Endocrine and Metabolism Alliance for Obesity,Chinese Medical Doctor Association Endocrinology and Metabolic Physicians Branch Obesity Study Group.Expert consensus on weight management clinic setting(2025 edition)[J].Chin J Diabetes Mellit,2025,17(7):801-805.(in Chinese)
[12] CHEN J H,XIANG J,ZHOU M Y,et al.Dietary timing enhances exercise by modulating fat-muscle crosstalk via adipocyte AMPKα2 signaling[J].Cell Metab,2025,37(6):1364-1380.
[13] 王天歌,陆洁莉,毕宇芳,等.中国糖尿病持续攀升新解:中年肥胖相关胰岛素抵抗成为主要威胁[J].中华内分泌代谢杂志,2020,36(3):198-200.
WANG T G,LU J L,BI Y F,et al.New insights into the growing diabetes epidemic in China:middle-aged obesity-related insulin resistance becomes the major threat[J].Chin J Endocrinol Metab,2020,36(3):198-200.(in Chinese)
[14] 叶真. 全人群全生命周期的糖尿病五级防治策略[J].中华糖尿病杂志,2024,16(9):937-944.
YE Z.Five-level diabetes control strategy for the entire population and full lifecycle[J].Chin J Diabetes Mellit,2024,16(9):937-944.(in Chinese)
[15] RUBINO F,CUMMINGS D E,ECKEL R H,et al.Definition and diagnostic criteria of clinical obesity[J].Lancet Diabetes Endocrinol,2025,13(3):221-262.
[16] 王晓娇,刘洪妍,孙丽萍,等.基于CiteSpace的国内外孕期体重管理研究热点的可视化分析[J].中国妇幼卫生杂志,2024,15(2):33-40.
WANG X J,LIU H Y,SUN L P,et al.Visual analysis of domestic and foreign research hotspots of pregnancy weight management based on CiteSpace[J].Chin J Women Child Health,2024,15(2):33-40.(in Chinese)
[17] 石小天,王珊,杨华昱,等.中国老年人体重指数和死亡的相关性:一项队列研究[J].中国全科医学,2025,28(22):2791-2797.
SHI X T,WANG S,YANG H Y,et al.Association between body mass index and mortality among older Chinese:a cohort study[J].Chin Gen Pract,2025,28(22):2791-2797.(in Chinese)
[18] 于婉,陈风,李娜,等.老年肌少症性肥胖:病因,诊断和治疗策略[J].中华老年医学杂志,2024(12):1545-1550.
YU W,CHEN F,LI N,et al.Sarcopenic obesity in the elderly:etiology,diagnosis,and treatment strategies[J].Chin J Geriatr,2024(12):1545-1550.(in Chinese)
[19] 田浩冬,陆玉坤,黄丽,等.老龄化背景下肌少症与肥胖的共病机制研究进展[J].生理学报,2025,77(5):905-924.
TIAN H D,LU Y K,HUANG L,et al.Research progress on the comorbidity mechanism of sarcopenia and obesity in the aging population[J].Acta Physiol Sin,2025,77(5):905-924.(in Chinese)
[20] 中国营养学会.中国高龄老年人体质指数适宜范围与体重管理指南(T/CNSS 021—2023)[J].中华流行病学杂志,2023,44(9):1335-1337.
Chinese Nutrition Society.Appropriate range of body mass index and body weight management guidelines for Chinese oldest old (T/CNSS 021—2023)[J].Chin J Epidemiol,2023,44(9):1335-1337.(in Chinese)
[21] 王丽君,胡培英,谢飞,等.成人超重肥胖分组分步健康管理效果分析[J].预防医学,2016,28(5):535-537.
WANG L J,HU P Y,XIE F,et al.Effect of stepwise and grouped health management for overweight and obese adults[J].China Prev Med J,2016,28(5):535-537.(in Chinese)
[22] 黄阳梅,沈旭娟,谢董颖,等.小学生体重监测信息反馈干预的效果评价[J].预防医学,2025,37(6):541-545.
HUANG Y M,SHEN X J,XIE D Y,et al.Effect of weight monitoring feedback intervention among primary school students[J].China Prev Med J,2025,37(6):541-545.(in Chinese)
[23] 曲伸. 中国体重管理及中心建设的现状与挑战[J].中华医学杂志,2025,105(37):3259-3265.
QU S.The current status and challenges of weight management and the construction of centers in China[J].NatI Med J China,2025,105(37):3259-3265.(in Chinese)
[24] 陈雨晴,都继微.可穿戴设备在成年人体重管理中应用的范围综述[J].中华现代护理杂志,2025,31(22):3063-3070.
CHEN Y Q,DU J W.Application of wearable devices in weight management for adults:a scoping review[J].Chin J Mod Nurs,2025,31(22):3063-3070.(in Chinese)
[25] 曾强. 关注体重管理最新进展,应对全球肥胖问题挑战[J].中华健康管理学杂志,2025,19(4):241-245.
ZENG Q.Pay attention to the latest developments in weight management and address the challenges of global obesity[J].Chin J Health Manag,2025,19(4):241-245.(in Chinese)
[26] 熊子涵,樊宁,赵月,等.数字营养技术在成人体重管理中的应用[J].四川大学学报(医学版),2025,56(4):900-906.
XIONG Z H,FAN N,ZHAO Y,et al.Application of digital nutrition technologies in adult weight management[J].J Sichuan Univ Med Sci,2025,56(4):900-906.(in Chinese)
[27] POKUSHALOV E,GARCIA C,PONOMARENKO A,et al.Optimizing weight loss with artificial intelligence:a randomized controlled trial of dietary-supplement prescriptions in adults with overweight and obesity[J].Clin Nutr ESPEN,2025,69:75-86.
[28] MCGROSKY A,LUKE A,ARAB L,et al.Energy expenditure and obesity across the economic spectrum[J/OL].Proc Natl Acad Sci USA,2025,122[2025-10-27].https://doi.org/10.1073/pnas.2420902122.
[29] MONTEIRO C A,CANNON G,LEVY R B,et al.Ultra-processed foods:what they are and how to identify them[J].Public Health Nutr,2019,22(5):936-941.
[30] JUUL F,MARTINEZ-STEELE E,PAREKH N,et al.The role of ultra-processed food in obesity[J].Nat Rev Endocrinol,2025,21(11):672-685.
[31] GRÜN F,BLUMBERG B.Environmental obesogens:organotins and endocrine disruption via nuclear receptor signaling[J].Endocrinology,2006,147(Suppl. 6):50-55.
[32] HEINDEL J J,LUSTIG R H,HOWARD S,et al.Obesogens:a unifying theory for the global rise in obesity[J].Int J Obes,2024,48(4):449-460.
[33] 陈澜,李兰星,林欣,等.超重/肥胖儿童青少年社会心理干预的最佳证据总结[J].现代医药卫生,2024,40(13):2211-2217.
CHEN L,LI L X,LIN X,et al.Summary of the best evidence for psychosocial interventions in overweight / obese children and adolescents[J].J Mod Med Health,2024,40(13):2211-2217.(in Chinese)
[34] RUBINO F,PUHL R M,CUMMINGS D E,et al.Joint international consensus statement for ending stigma of obesity[J].Nat Med,2020,26(4):485-497.
[35] The Lancet Diabetes Endocrinology.Redefining obesity:advancing care for better lives[J/OL].Lancet Diabetes Endocrinol,2025,13[2025-10-27].https://doi.org/10.1016/S2213-8587(25)00004-X. |
| [1] |
LU Jie, ZHANG Ke, WU Ya, WANG Yue, ZHANG Yue, LU Ye, WU Zhouli, REN Zhihua, HUANG Yiwen. Comparison of the effect of obesity indicators in predicting cardiovascular and cerebrovascular diseases among patients with type 2 diabetes mellitus[J]. Preventive Medicine, 2025, 37(9): 886-891. |
|
|
|
|
